Xencor, Inc. (XNCR)
13.06
+0.61
(+4.90%)
USD |
NASDAQ |
Apr 17, 16:00
13.06
0.00 (0.00%)
Pre-Market: 20:00
Xencor Free Cash Flow : -138.27M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Rigel Pharmaceuticals, Inc. | 75.66M |
| Ultragenyx Pharmaceutical, Inc. | -487.00M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -101.06M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -51.71M |
| Cash from Investing (Quarterly) | 72.90M |
| Cash from Financing (Quarterly) | 4.596M |
| Free Cash Flow Per Share (Quarterly) | -0.7086 |
| Free Cash Flow to Equity (Quarterly) | -38.19M |
| Free Cash Flow to Firm (Quarterly) | -41.38M |
| Free Cash Flow Yield | -14.26% |